Enovis (ENOV) Cash from Financing Activities (2010 - 2026)
Enovis' (ENOV) quarterly Cash from Financing Activities came in at -$50.6 million in Q3 2026, down 911.51% year-over-year from $6.2 million in Q3 2025, and down 294.31% quarter-over-quarter from $26.0 million in Q2 2026.
Analysis
Enovis (ENOV) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Cash from Financing Activities for 17 consecutive years, with -$50.6 million the latest figure, recorded in Q3 2026.
- On a quarterly basis, Cash from Financing Activities fell 911.51% year-over-year to -$50.6 million in Q3 2026; TTM through Jul 2026 was -$134.4 million, a 461.25% decrease from a year earlier, with the FY2025 full-year figure at -$52.4 million, down 106.19% from the prior year.
- Cash from Financing Activities was -$50.6 million for Q3 2026 at Enovis, down from $26.0 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $864.5 million in Q1 2024 and troughed at -$495.5 million in Q3 2022.
- A 5-year average of $24.0 million and a median of $1.2 million in 2024 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities jumped 3429.02% in 2024 and tumbled 24837.16% in 2025, its largest moves.
- Over 5 years, Cash from Financing Activities stood at $41.6 million in 2022, then sank by 93.3% to $2.8 million in 2023, then sank by 819.97% to -$20.1 million in 2024, then tumbled by 263.12% to -$72.9 million in 2025, then jumped by 30.65% to -$50.6 million in 2026.
- The last three Cash from Financing Activities figures came in at -$50.6 million (Q3 2026), $26.0 million (Q2 2026), and -$72.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Enovis | 1.07 Bn | 1.06 Bn | 359.25 Mn | -50.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | -50.57 Mn |
| Apr 3, 2026 | 26.02 Mn |
| Dec 31, 2025 | -72.92 Mn |
| Oct 3, 2025 | -36.91 Mn |
| Jul 4, 2025 | 6.23 Mn |
| Apr 4, 2025 | 51.19 Mn |
| Dec 31, 2024 | -20.08 Mn |
| Sep 27, 2024 | -148,000.00 |
| Jun 28, 2024 | 2.51 Mn |
| Mar 29, 2024 | 864.54 Mn |
| Dec 31, 2023 | 2.79 Mn |
| Sep 29, 2023 | -13.70 Mn |
| Jun 30, 2023 | 114.21 Mn |
| Mar 31, 2023 | 24.50 Mn |
| Dec 31, 2022 | 41.63 Mn |
| Sep 30, 2022 | -456,000.00 |
| Jul 1, 2022 | -495.48 Mn |
| Apr 1, 2022 | -10.82 Mn |
| Dec 31, 2021 | 473.07 Mn |
| Oct 1, 2021 | 40.15 Mn |